Vaccines and Public Health | Johns Hopkins | Bloomberg School of Public Health

illustration of microscopic view of marburg virus

What We Know About Rwanda’s Marburg Virus Outbreak

October 16, 2024

How Rwanda is working to contain its first-ever outbreak of the deadly virus—including by testing a new vaccine.

Infectious Diseases

International Health

Vaccines

Bloomberg School

An Update on COVID Vaccines

April 11, 2022

What's next for COVID vaccines—and why do we need more? The bottom line: the more vaccines we have that people are willing to take, the better off we're going to be.

COVID-19

Vaccines

Bloomberg School

A New Shot Prevents Serious Illness from RSV

March 30, 2022

A monoclonal antibody that protects infants from respiratory syncytial virus-associated lung infection shows promise in clinical trials.

Health Equity

Infectious Diseases

Vaccines

Bloomberg School

sther Sambiri, left, stands with fellow vaccine advocates outside the Nyanga, Zimbabwe, district government office on Dec. 16, 2021. Image: Farai Mutsaka

In Zimbabwe, COVID-19 Vaccine Mistrust Stokes HPV Vaccination Fears

March 24, 2022

4,000 young volunteers are spreading across Zimbabwe, knocking on doors and encouraging their peers (and skeptical older people) to get the HPV vaccine.

International Health

Vaccines

Global Health NOW

Here We Go Again: The BA.2 Version of Omicron

March 22, 2022

Even as BA.2 and “deltacron” set off feelings of panic or exhaustion, vaccinations and boosters continue to provide the best protection.

COVID-19

Infectious Diseases

Vaccines

Bloomberg School

Should I Vaccinate My Kids Against COVID-19? Yes. Here’s Why.

March 11, 2022

Covid shots keep kids out of the hospital and in school—and can prevent serious health issues like long Covid and MISC-C.

COVID-19

Vaccines

Child and Adolescent Health

Bloomberg School

Vaccines Faculty Experts

Looking for prominent public health experts in the field of vaccines? They’re here at the Bloomberg School of Public Health.

William John Moss

Professor

Epidemiology

Anna P. Durbin

Professor

International Health

Anna Durbin, MD, studies experimental vaccines for SARS-CoV-2, dengue, West Nile, Zika, malaria, and more in human clinical trials and in controlled human infection studies.

Daniel Salmon

Professor

International Health

Daniel Salmon, PhD ’03, MPH, is a vaccinologist who conducts epidemiological and behavioral studies to assess the safety of vaccines and improve vaccine decision-making.

Ruth Karron

Professor

International Health

Vaccines

Vaccines Headlines

What We Know About Rwanda’s Marburg Virus Outbreak

An Update on COVID Vaccines

A New Shot Prevents Serious Illness from RSV

In Zimbabwe, COVID-19 Vaccine Mistrust Stokes HPV Vaccination Fears

Here We Go Again: The BA.2 Version of Omicron

Should I Vaccinate My Kids Against COVID-19? Yes. Here’s Why.

Vaccines Faculty Experts

William John Moss

Anna P. Durbin

Daniel Salmon

Ruth Karron

Departments

Programs

Centers & Institutes

Upcoming Events